Division Chief, Multiple Myeloma
David Siegel, M.D., Ph.D., chief of the Division of Multiple Myeloma, is one of the nation’s foremost authorities on multiple myeloma. Most recently, Dr. Siegel served the lead investigator of the pivotal multi-center, phase IIb study involving 30 cancer centers in North America that led to the FDA’s fast-track approval of Kyprolis (carfilzomib) for relapsed multiple myeloma patients.
years treating myeloma: 35
Number of Myeloma Patients Treated Annually:
Details & contact info
92 2nd Street
Hackensack, NJ, United States, 7601
Send a message to David Siegel, MD, PHD